External Source

Pathogenic Tp53 Mutations Associated With Poor Prognosis In Pediatric Aml

2022 5:45
Synopsis
Adam Lamble, MD, at the Cancer and Blood Disorders Center, Seattle Children's Hospital, discusses a new study showing that ...

You Might Also Like

TP53-Mutant AML: A Pathology-Guided Journey Through Diagnostic Principles 23:04
Tp53-mutant Aml: A Pathology-guided Journey Through Diagnost...
2021
Challenges in treating patients with TP53-mutated AML and future outlooks 1:53
Challenges In Treating Patients With Tp53-mutated Aml And Fu...
2023
Challenges in Treating TP53-Mutated AML, Hope on the Horizon 3:11
Challenges In Treating Tp53-mutated Aml, Hope On The Horizon
2023
Is a TP53 mutation always a poor prognostic marker for transplantation in AML? 5:12
Is A Tp53 Mutation Always A Poor Prognostic Marker For Trans...
2021
Six New High-Risk Alterations Identified for Pediatric AML 4:34
Six New High-risk Alterations Identified For Pediatric Aml
2023
The prognostic impact of TP53 mutation in MPNs 0:46
The Prognostic Impact Of Tp53 Mutation In Mpns
2022
Treatment of TP53-Mutated AML 7:20
Treatment Of Tp53-mutated Aml
2019
Significance of p53 mutations in AML 1:03
Significance Of P53 Mutations In Aml
2020
Why should we assess variant allelic frequency in TP53-mutated AML? 2:53
Why Should We Assess Variant Allelic Frequency In Tp53-mutat...
2020
APR-246 in TP53 mutated MDS and AML 3:00
Apr-246 In Tp53 Mutated Mds And Aml
2020
Tolerability and efficacy of magrolimab plus azacitidine in TP53-mutated AML patients 1:57
Tolerability And Efficacy Of Magrolimab Plus Azacitidine In ...
2022
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.